A growing body of evidence suggests that the presence of brain changes associated with Alzheimer’s disease does not always lead to memory loss or cognitive decline. A recent study published in Acta Neuropathologica Communications highlights cases of individuals who, despite carrying key pathological features of the disease, maintain normal cognitive function.
What is asymptomatic Alzheimer’s disease
The research focuses on a condition known as asymptomatic Alzheimer’s disease (AsymAD). In these cases, individuals have amyloid plaques and neurofibrillary tangles in the brain, which are typically linked to Alzheimer’s, but do not show clinical symptoms. This challenges the assumption that such brain changes inevitably result in dementia.
Key molecular findings
Researchers identified a distinct molecular signature associated with this apparent resilience. Central to the findings is the protein Chromogranin A (CgA), which may act as a regulator influencing whether pathological changes translate into cognitive impairment.
Brains that remained functionally intact showed reduced activity in genes linked to tau protein accumulation, alongside stronger activation of cellular protection mechanisms.
The findings point to the existence of biological processes that may help protect brain function, even in the presence of disease-related changes.
Researchers suggest that understanding this “resilience biology” could contribute to the development of new preventive or therapeutic strategies targeting Alzheimer’s progression.
Rethinking established assumptions
Beyond its scientific relevance, the study raises broader questions about how Alzheimer’s disease is understood. It suggests that the relationship between brain pathology and cognitive decline may be more complex than previously thought.
Rather than a direct and inevitable progression, the brain may, in some cases, activate internal defence mechanisms that preserve memory and thinking.
Source: Acta Neuropathologica Communications
